Health & bio
AstraZeneca Expands Tezspire Asthma Label
On April 13, the FDA granted AstraZeneca's asthma drug Tezspire (tezepelumab-ekko) expanded approval, broadening its indicated uses.
Primary sources · 1
On April 13, the FDA granted AstraZeneca's asthma drug Tezspire (tezepelumab-ekko) expanded approval, broadening its indicated uses.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.